As of April 16, 2025, BioXcel Therapeutics (BTAI) has a market cap of $9.952 million USD. According to our data, BioXcel Therapeutics is ranked No.8816 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 16, 2025 | $9.95 M |
-46.37%
|
Dec 31, 2024 | $18.56 M |
-87.33%
|
Dec 29, 2023 | $0.15 B |
-86.27%
|
Dec 30, 2022 | $1.07 B |
5.66%
|
Dec 31, 2021 | $1.01 B |
-56.00%
|
Dec 31, 2020 | $2.29 B |
216.22%
|
Dec 31, 2019 | $0.73 B |
278.50%
|
Dec 31, 2018 | $0.19 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() ACADIA Pharmaceuticals
ACAD
|
$2.50 B |
-0.000 M
|
![]() USA
|
![]() Intra-Cellular Therapies
ITCI
|
$14.05 B |
0.000 M
|
![]() USA
|
![]() Sage Therapeutics
SAGE
|
$0.46 B |
0.000 M
|
![]() USA
|
![]() Axsome Therapeutics
AXSM
|
$5.06 B |
-0.000 M
|
![]() USA
|
![]() Alkermes
ALKS
|
$4.61 B |
-0.000 M
|
![]() Ireland
|
![]() Neurocrine Biosciences
NBIX
|
$9.51 B |
0.000 M
|
![]() USA
|
![]() Otsuka Holdings
4578.T
|
$25.08 B |
-0.204 B
|
![]() Japan
|
![]() Eli Lilly
LLY
|
$679.94 B |
-0.022 M
|
![]() USA
|
![]() Johnson & Johnson
JNJ
|
$370.20 B |
0.003 M
|
![]() USA
|
![]() Pfizer
PFE
|
$127.27 B |
-0.003 M
|
![]() USA
|
![]() AstraZeneca
AZN
|
$210.42 B |
-0.005 M
|
![]() UK
|
![]() Bristol-Myers Squibb
BMY
|
$101.74 B |
-0.001 M
|
![]() USA
|
Market Cap | = | BTAI Stock Price | * | BTAI Shares Outstanding |
= | $1.82 | * | 5.47 M | |
= | $9.95 M |